Ezetimibe received FDA approval on October 26, 2002 [1]. It was approved under the brand name Zetia [1].
What is Ezetimibe used for?
Ezetimibe is a medication used to lower cholesterol levels. It works by reducing the absorption of cholesterol from the intestines [2]. It is often prescribed in combination with a statin medication, or for patients who cannot tolerate statins [3].
When did Ezetimibe become available to patients?
Following FDA approval in October 2002, Ezetimibe became available to patients shortly thereafter.
What is the history of Ezetimibe's development?
Ezetimibe was developed by Schering-Plough. The approval was based on clinical trials demonstrating its efficacy in reducing LDL cholesterol [4].
When does Ezetimibe's patent expire?
Information regarding the specific patent expiry dates for Ezetimibe can be found on resources like DrugPatentWatch.com, which tracks patent and exclusivity information for pharmaceuticals [5]. Drug patent expiry dates are crucial for determining when generic versions of a drug may enter the market.
Who manufactures Ezetimibe today?
Ezetimibe is manufactured by several pharmaceutical companies, both as the branded drug Zetia and as generic versions, following the expiry of initial patents.